
Blood Thinner “Dabigatran” May Effectively Delay Alzheimer’s
PROGRESS IN THE NEWS – VIDEO & ARTICLE: In the lab, Alzheimer’s was delayed by FDA-approved “Dabigatran” (Pradaxa®), commonly used to clear blood clots. Can
PROGRESS IN THE NEWS – VIDEO & ARTICLE: In the lab, Alzheimer’s was delayed by FDA-approved “Dabigatran” (Pradaxa®), commonly used to clear blood clots. Can
MEDICATION VIDEO + ARTICLE: Scientists found drug developed for diabetes “significantly reversed memory loss” in Alzheimer’s mice, through a triple method of action. See why
CLINICAL TRIAL: In Alzheimer’s trials, Leuprolide (an FDA approved cancer drug) stabilized memory loss for a full year. This is the first time any therapy
Diabetics get a lot more dementia than the average person. Yet diabetics taking FDA-approved Actos get a lot LESS dementia than the average person – 47% less. That’s about half the rate. Find out more.
A startling new link shows Alzheimer’s in transplant patients is significantly lower, in fact almost absent, when compared to national data from the general population.
VIDEO + ARTICLE: A new epilepsy drug could be used to treat Alzheimer’s patients. Find out about this new experimental approach.
Find out how cotinine boosted Aricept’s ability to improve learning and memory. (Aricept is the most popular Alzheimer’s drug. Cotinine is produced by the body when a person wears a nicotine patch. )
POTENTIAL TREATMENT: “Pre-dementia” is a common nickname for aMCI (amnestic Mild Cognitive Impairment). aMCI causes memory to decline more than what’s expected from normal aging,
In a recent study, insulin spray was delivered through the nose to people with Alzheimer’s and MCI. Learn about the memory improvements they achieved.
UPCOMING THERAPIES: Researchers know more about old drugs than new ones. That’s why they put a lot of effort into "repurposing" existing drugs to cure
Kimberly Warnick, Certified Dementia Practitioner and Care Navigator
Selling Alzheimer’s books takes time – buyers rarely commit right away. Smart authors plan for the long game, offering gentle, repeated reminders to buy. No tool does this more effectively or simply than the Alzheimer’s & Dementia Weekly Newsletter service. Keep your book—and its message—at the center of your readers’ attention.
A new pineapple turmeric apple cider vinegar blend from Bragg is turning heads—not just for its flavor, but for its potential brain-boosting benefits. Could this tangy tonic play a role in Alzheimer’s prevention?
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.